Evidence map›Paper›PMID 26652902›Full record

ArticleMolecular endocrinology (Baltimore, Md.)2016

Differential Regulation of Progesterone Receptor-Mediated Transcription by CDK2 and DNA-PK.

Lindsey S Treviño, Michael J Bolt, Sandra L Grimm, Dean P Edwards, Michael A Mancini, Nancy L Weigel

Open access · bronzeAbstract read
In one paragraph

Article in Molecular endocrinology (Baltimore, Md.), 2016. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 11 papers.

0numbers the graph read from it
0cells of the map it votes in
11citing papers in PubMed
0.7field-weighted citation impact, top 22% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

11 citing papers in PubMed, 24 citations in OpenAlex.

  1. Review
  2. Article
  3. Article
  4. A molecular toolbox to study progesterone receptor signaling.Journal of mammary gland biology and neoplasia · 2023
    Article
  5. Review
  6. Article
  7. Review
  8. Article
  9. Pleiotropic Impact of DNA-PK in Cancer and Implications for Therapeutic Strategies.Clinical cancer research : an official journal of the American Association for Cancer Research · 2019
    Article
  10. Article
  11. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors at 1 institution in 1 country.

Lindsey S TreviñoDepartments of Molecular and Cellular Biology (L.S.T., M.J.B., S.L.G., D.P.E., M.A.M., N.L.W.) and Pathology and Immunology (S.L.G., D.P.E.), Baylor College of Medicine, Houston, Texas 77030.
Michael J BoltDepartments of Molecular and Cellular Biology (L.S.T., M.J.B., S.L.G., D.P.E., M.A.M., N.L.W.) and Pathology and Immunology (S.L.G., D.P.E.), Baylor College of Medicine, Houston, Texas 77030.
Sandra L GrimmDepartments of Molecular and Cellular Biology (L.S.T., M.J.B., S.L.G., D.P.E., M.A.M., N.L.W.) and Pathology and Immunology (S.L.G., D.P.E.), Baylor College of Medicine, Houston, Texas 77030.
Dean P EdwardsDepartments of Molecular and Cellular Biology (L.S.T., M.J.B., S.L.G., D.P.E., M.A.M., N.L.W.) and Pathology and Immunology (S.L.G., D.P.E.), Baylor College of Medicine, Houston, Texas 77030.
Michael A ManciniDepartments of Molecular and Cellular Biology (L.S.T., M.J.B., S.L.G., D.P.E., M.A.M., N.L.W.) and Pathology and Immunology (S.L.G., D.P.E.), Baylor College of Medicine, Houston, Texas 77030.
Nancy L WeigelDepartments of Molecular and Cellular Biology (L.S.T., M.J.B., S.L.G., D.P.E., M.A.M., N.L.W.) and Pathology and Immunology (S.L.G., D.P.E.), Baylor College of Medicine, Houston, Texas 77030.
Baylor College of Medicine · US

Funding

Tumor BiologyP30CA125123 · NCI · BAYLOR COLLEGE OF MEDICINE · PI DAVID R ROWLEY · 2007 to 2026
$73.9M
Tissue Analysis & Molecular Imaging CoreP30DK056338 · NIDDK · BAYLOR COLLEGE OF MEDICINE · PI Geoffrey A Preidis · 2001 to 2026
$28.3M
The functional role of microRNAs in the normal mammary glandP01HD038129 · NICHD · UNIVERSITY OF COLORADO DENVER · PI ANDERSON, STEVEN M · 2000 to 2015
$15.2M
REGULATION OF HUMAN STEROID RECEPTORS BY PHOSPHORYLATIONR01CA057539 · NCI · BAYLOR COLLEGE OF MEDICINE · PI WEIGEL, NANCY L. · 1993 to 2010
$4.0M
STEROID ANTAGONISTS AND RESISTANCE IN BREAST CANCERR01DK049030 · NIDDK · UNIVERSITY OF COLORADO DENVER · PI EDWARDS, DEAN P · 1994 to 2012
$3.1M
Developmental Reprogramming of Prostate Carcinogenesis by BPARC2ES018789 · NIEHS · UNIVERSITY OF TX MD ANDERSON CAN CTR · PI HO, SHUK-MEI, MANCINI, MICHAEL A. · 2009 to 2010
$1.9M
Examining the cell cycle-dependence of progesterone receptor activityF32GM103080 · NIGMS · BAYLOR COLLEGE OF MEDICINE · PI TREVINO, LINDSEY STARR · 2012 to 2013
$61k
NCI NIH HHS P30 CA125123NCI NIH HHS P30 NCI CA125123NCI NIH HHS R01 CA057539NCI NIH HHS R01 CA57539NICHD NIH HHS P01 HD038129NIDDK NIH HHS P30 DK056338NIDDK NIH HHS P30DK56338NIDDK NIH HHS R01 DK049030NIDDK NIH HHS R01DK049030NIEHS NIH HHS 5RC2ES018789-02NIEHS NIH HHS RC2 ES018789NIGMS NIH HHS F32 GM103080NIGMS NIH HHS F32GM103080
6 · The paper itself

Abstract

Progesterone receptor (PR) function is altered by cell signaling, but the mechanisms of kinase-specific regulation are not well defined. To examine the role of cell signaling in the regulation of PR transcriptional activity, we have utilized a previously developed mammalian-based estrogen-response element promoter array cell model and automated cell imaging and analysis platform to visualize and quantify effects of specific kinases on different mechanistic steps of PR-mediated target gene activation. For these studies, we generated stable estrogen-response element array cell lines expressing inducible chimeric PR that contains a swap of the estrogen receptor-α DNA-binding domain for the DNA-binding domain of PR. We have focused on 2 kinases important for steroid receptor activity: cyclin-dependent kinase 2 and DNA-dependent protein kinase. Treatment with either a Cdk1/2 inhibitor (NU6102) or a DNA-dependent protein kinase inhibitor (NU7441) decreased hormone-mediated chromatin decondensation and transcriptional activity. Further, we observed a quantitative reduction in the hormone-mediated recruitment of select coregulator proteins with NU6102 that is not observed with NU7441. In parallel, we determined the effect of kinase inhibition on hormone-mediated induction of primary and mature transcripts of endogenous genes in T47D breast cancer cells. Treatment with NU6102 was much more effective than NU7441, in inhibiting induction of PR target genes that exhibit a rapid increase in primary transcript expression in response to hormone. Taken together, these results indicate that the 2 kinases regulate PR transcriptional activity by distinct mechanisms.

Indexed as

Transcription, GeneticChromonesCyclin-Dependent Kinase 2DNA-Activated Protein KinaseGonanesHeLa CellsHumansMediator ComplexMifepristoneModels, BiologicalMorpholinesPromegestonePurinesReceptors, ProgesteroneRecombinant Proteins8-dibenzothiophen-4-yl-2-morpholin-4-yl-chromen-4-oneCDK2 protein, humanChromonesCyclin-Dependent Kinase 2DNA-Activated Protein KinaseGonanesMediator ComplexMifepristoneMorpholinesNU6102onapristonePromegestonePurinesReceptors, ProgesteroneRecombinant Proteins

Identifiers

PMID26652902
PMCPMC4792227
OpenAlexW2190696194

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.